Treatment of dry eye disease in younger patients requires careful consideration of safety, age appropriateness, and duration of therapy. This video addresses key clinical questions around the minimum age for initiating lifitegrast, its potential use in pediatric patients, and recommended duration of therapy based on available evidence and clinical experience.
By : Dr. Eric Donnenfled
Subscribe to our newsletter and be the first to receive insights, updates, and expert tips on optimizing your financial management.